Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03956680
Title An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

Advanced Solid Tumor

Therapies

Ipilimumab + Nivolumab

BMS-986301

Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Local Institution - 0003 Active, not recruiting Chicago Illinois 60637 United States Details
Local Institution - 0005 Completed Saint Louis Missouri 63110 United States Details
Local Institution - 0006 Active, not recruiting Pittsburgh Pennsylvania 15232-1305 United States Details
Local Institution - 0002 Active, not recruiting Nashville Tennessee 37232 United States Details
Local Institution - 0001 Recruiting Toronto Ontario M5G 1Z5 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field